Powered by
-
LLY Stock Chart
Historical LLY Prices
Eli Lilly Stock Analysis
Rating: Strong Buy
Total Grade: A
Analysis Breakdown
| LLY Stock Grade: | A |
| Fundamental Grade: | B |
| Quantitative Grade: | A |
| LLY Earnings | |
| Earnings Growth: | A |
| Earnings Momentum: | A |
| Earnings Surprises: | C |
| Analyst Earnings Revisions: | B |
| LLY Financial Information | |
| Sales Growth: | C |
| Operating Margin Growth: | A |
| Cash Flow: | B |
| Return on Equity: | C |
Eli Lilly Stock: Weekly View
| This Week: | A |
|---|---|
| Last Week: | B |
| Two Weeks Ago: | B |
LLY Stock predictions, Articles, and Eli Lilly News
- From InvestorPlace
- From the Web
-
5 Stocks to Sell After the Midterm Election - November 12, 2018
Trump and House Democrats look poised to make deals that will hurt these stocks to sell. Here's what investors need to know. Continue…
-
5 Top Stock Trades for Wednesday: AMD’s Teaming Up With Amazon? - November 6, 2018
Earnings set to the tone for Toyota, CVS Health, Eli Lilly and Mylan as our top stock trades. But midterms will set the tone for the week. Continue…
-
3 Healthcare Stocks to Buy Amid the Carnage - October 15, 2018
Bears have emerged from hibernation. But not all stocks are suffering their wrath. Here are three healthcare stocks to buy. Continue…
-
3 Big Stock Charts for Friday: PPL, Macy’s and Eli Lilly - October 5, 2018
The stock charts of LLY, M and PPL have earned a second look before the trading week comes to a close. Continue…
-
Trade of the Day: Eli Lilly (LLY) - September 27, 2018
We are opening a new bullish trade on Eli Lilly (NYSE:LLY), the $106 billion manufacturer of pharmaceutical products. LLY skyrocketed higher after its last earnings announcement, in which the company not only beat revenue and earnings expectations but also announced it would be spinning out part of its Elanco Animal Health division in an initial public offering (IPO). Continue…
-
3 Big Stock Charts for Wednesday: FMC, Eli Lilly and Hewlett Packard Enterprise - September 5, 2018
The stock charts of LLY, HPE and FMC are shaping up as your top trading prospects on this week's hump-day. Continue…
-
Biogen Is the Right Alzheimer’s Stock … At the Wrong Time - July 10, 2018
BIIB stock jumped on Friday, and for good reason. It's not a buy at these lofty levels, but Biogen has at least earned a spot on your watchlist. Continue…
-
ARMO Biosciences Inc Shares Skyrocket on $1.6 B Eli Lilly Deal - May 10, 2018
ARMO Biosciences (ARMO) stock is skyrocketing today on news of a massive $1.60 billion deal that will have Eli Lilly (LLY) acquiring it. Continue…
-
Pfizer Inc. Stock Is Boring But Great for Your Portfolio’s Health - May 1, 2018
Fundamentally PFE is too cheap. So go long on this earnings dip inside a nervous market. Management is proven for decades and is bankable for the future. Continue…
-
Eli Lilly And Co Produced a Monstrous Q1 Beat, But Is It Enough? - April 24, 2018
LLY stock delivered outstanding results for its just released Q1 report, but significant questions about its future direction remain. Continue…
